More than an assessment – a blueprint

Unlock the full power of your clinical data with a blueprint to achieving an enterprise clinical data management governance strategy

Unlock a strategic growth plan

Clinical data is the most important asset health systems have today, yet most healthcare systems are not maximizing the value of their clinical data for one simple reason – they don’t have a plan.

​Let Q-Centrix’s team of experts walk you step-by-step through the process, delivering a custom assessment that takes your organization’s goals and growth plans into account and delivers everything from initial data review, industry benchmarks, identifying risks and opportunities, and a strategic growth plan.​

Hospitals spend an average of

$500K- $650K

annually on clinical quality data*

(based on 160 beds)

Tools provided as part of the assessment

Participation and technology catalog

Health system team efficiency

Data integrity review

Licensure utilization assessment

Total cost of data management

Data utilization analysis

Registry value-vetting checklist

Physician perception of registry data

Strategic growth action plan

Oncology platform analysis

Research data analysis

More than


of hospital registry managers don't know how their registry data is being utilized*

*Stats based on data from >100 hospitals

Hospitals experience


abstraction inefficiency when using internal staff*

What our team will deliver

previous arrow
next arrow

Key milestones for an effective assessment

In addition to having a highly engaged senior executive, the below are the proven steps to an insightful assessment.


Expectation setting with executive stakeholder


Full stakeholder meeting to review the project charter and begin the assessment process​

Registry & Stakeholder Identification

Identification of all current registries, primary physicians, and administrative support teams


Generate, collect, and validate all data audit and survey forms for inclusion in final report​

Initial Data Review

Share preliminary findings with the Executive Stakeholders and discuss outstanding areas for validation​

Final Strategy Presentation

Share final report which combines strategic growth initiatives for the health system with assessment findings to create a roadmap for achieving greater centralization and utilization of clinical data​
Vetting the value, clinical data governance
White paper

Vetting the value, clinical data governance

As a first step in an enterprise approach to clinical management, health systems must create a governance process to determine what measures will truly impact their performance.

Key findings:
There are many opportunities to realize the value of participation in registries outside the clinical insights. In fact, the competitive advantages have become almost equally as important. There are resources and partnerships available to help maximize value, and Q-Centrix is one of them.

Download this White Paper

Q-Centrix Experts

Daniella Wood

Analyst, Enterprise Services

Sara Bienvenu

Manager, Clinical Quality Growth

Doug McGill

Managing Director, Advisory Solutions

Eric Crites

Vice President, Enterprise Services